UTI Mid Cap Fund Direct Growth
Equity
Direct
Mid-Cap
NAV as on 04-02-2025
₹ 312.41
▲0.8%
1D
Inception Returns
19.5%
/yr
About UTI Mid Cap Fund Direct Growth
UTI Mid Cap Fund Direct Growth is an equity fund. This fund was started on 1 January, 2013. The fund is managed by Ankit Agarwal. The fund could potentially beat inflation in the long-run.
Key Parameters
- UTI Mid Cap Fund Direct Growth has ₹11997 Cr worth of assets under management (AUM) as on Nov 2024 and is less than category average.
- The fund has an expense ratio 0.9.
Returns
UTI Mid Cap Fund Direct Growth has given a CAGR return of 19.47% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 12.45%, 15.36% and 22.68% respectively.
Holdings
UTI Mid Cap Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Consumer Cyclical, Financial Services, Industrial, Tech, Health, Basic Materials, Communication, Real Estate, Consumer Defensive, Utilities. Its top holdings are Coforge Ltd, Persistent Systems Ltd, PB Fintech Ltd, Polycab India Ltd, Phoenix Mills Ltd
Taxation
As it is a mid-cap mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 15%For long term (more than 1 year) capital gains will be taxed at 10% without indexation benefitDividends will always be taxed at slab rate. Gains upto Rs 1 lakh are exempt in case of long term.
Investment objective of UTI Mid Cap Fund Direct Growth
The objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of mid cap companies. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
Minimum Investment and lockin period
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 500.00. UTI Mid Cap Fund Direct Growth has no lock in period.
Historical NAV & Returns
Absolute
▲
▼
2041 people have invested ₹ 2.5Cr in UTI Mid Cap Fund Direct Growth in the last three months
INDmoney Rank for UTI Mid Cap Fund Direct Growth
Powered by IND quant engine
15
/19
28% Performance
34% Risk Management
46% Cost
15 out of 19 among mid-cap
Beats FD returns for both 3Y & 5Y
3Y returns in the bottom 25% of the category
UTI Mid Cap Fund Direct Growth Overview
| Expense ratio | 0.89% |
Benchmark | S&P BSE Midcap TR INR |
| AUM | ₹11997 Cr |
| Inception Date | 1 January, 2013 |
| Min Lumpsum/SIP | ₹5000/₹500 |
Exit Load | 1.0% |
| Lock In | No Lock-in |
TurnOver | 36.32% |
| STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
| LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
| Risk |   Very High Risk |
Trailing Returns
as on (04-Feb-25)
Fund Distribution
as on (30-Nov-24)
Mid cap
67.5%
Small cap
23.1%
Large cap
6.9%
Sector Allocation
Consumer Cyclical
19.5%
Financial Services
17.7%
Industrial
17.5%
Tech
13.2%
Health
12.1%
Basic Materials
10.1%
Communication
3.5%
Real Estate
2.2%
Consumer Defensive
2.1%
Utilities
1.9%
All changes are between Sep'24 and Nov'24
- This fund’s returns stands at 1.04% whereas the fund’s underlying benchmark Nifty Midcap 150 returns stands at -0.54% as on Nov'24
- This fund outperformed Nifty Midcap 150 by 1.59% in Nov'24
- AUM of the fund stands at 12K Cr as of Dec'24
- AUM decreased by 32.1 Cr between Dec'24 and Nov'24
Top Stocks bought last month
Polycab India Ltd's allocation increased from 1.89% to 2.1%
Phoenix Mills Ltd's allocation increased from 2.01% to 2.16%
Dixon Technologies (India) Ltd's allocation increased from 1.33% to 1.48%
Top Stocks sold last month
Persistent Systems Ltd's allocation decreased from 2.28 % to 2.21 %
Alkem Laboratories Ltd's allocation decreased from 2.02 % to 1.9 %
Ajanta Pharma Ltd's allocation decreased from 1.88 % to 1.84 %
Small Cap allocation has gone up from 23% to 23.1%
Mid Cap allocation has gone up from 66.4% to 67.5%
Large Cap allocation has gone down from 6.9% to 6.9%
Cash allocation has gone down from 3.7% to 2.2%
Top 3 Sectors in December were Consumer Cyclical, Industrial & Financial Services
Dec'24
Consumer Cyclical
20%
Financial Services
18%
Industrial
18%
Nov'24
Consumer Cyclical
20%
Industrial
19%
Financial Services
18%
Top Growth Drivers | 1M Return |
|---|---|
 L&T Technology Services Ltd | 13% |
 CreditAccess Grameen Ltd | 9.6% |
 Indian Bank | 2.1% |
Loading...
We are taking more time than usual
Ankit Agarwal
Fund Manager of UTI Mid Cap Fund Direct Growth, since 30 August 2019
Top funds managed
Fund House
UTI Asset Management Co Ltd
Total Schemes
Total AUM
₹2.36L Cr
as on 29-Nov-2024
Address
PMS Division, UTI - Tower, “Gn” Block, Bandra Kurla Complex, Mumbai- 400051
Phone
+912266786666
Website
pms_care@uti.co.in
Mutual Fund Insights
In the last 3 years, Motilal Oswal Midcap Direct Growth has given 29.56% return, outperforming this fund by 14.2% per annum.
This fund expense ratio is slightly on the lower side within the category (mid-cap). Its expense ratio is 0.89% which is lower than the category average expense ratio of 1.12%.
Over the last 6 months, this fund has increased expense ratio by 11.2% moving from 0.80 to 0.89.
In the last 5 years, Quant Mid Cap Fund Growth Option Direct Plan has given 31.9% return, outperforming this fund by 9.22% per annum.
In the last 1 year, Motilal Oswal Midcap Direct Growth has given 34.2% return, outperforming this fund by 21.76%.
Over the last 3 months, this fund has experienced a 5.6% drop in AUM moving from 12.70K Cr to 11.99K Cr.
UTI Mid Cap Fund Direct Growth Highlights
Very High Risk
Investors understand that their principal will be at Very High Risk
About the fund
This fund has delivered an average annual returns of 19.47% since inception which is less than its category average return of 20.27%
Fund Allocations
This fund has an allocation of 97.84% in Equity, 0% in Debt and 2.16% in Cash related instruments
AUM size ₹11997 Cr
This fund has AUM of ₹11997 Cr which is less than its category average of ₹ 13276 Cr
Expense Ratio 0.89%
This fund has an expense ratio of 0.89% which is less than its category average expense ratio of 1.23%
Frequently Asked Questions for UTI Mid Cap Fund Direct Growth
The current NAV of UTI Mid Cap Fund Direct Growth is ₹312.41 as on 04-Feb-2025.
Existing (Absolute + CAGR) as on 04-Feb-2025.
UTI Mid Cap Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | -8.26% | -8.26% |
6 Month Returns | -8.92% | -8.92% |
1 Year Returns | 12.45% | 12.45% |
3 Years Returns | 53.51% | 15.36% |
5 Years Returns | 177.89% | 22.68% |
With INDmoney, the process of investing is very simple and involves zero commission.
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
0.89% as on January 2025
₹11997 Cr as on January 2025
Coforge Ltd(2.73%), Persistent Systems Ltd(2.36%), PB Fintech Ltd(2.27%), Polycab India Ltd(2.22%), Phoenix Mills Ltd(2.14%) as on January 2025
Consumer Cyclical(19.09%), Financial Services(17.32%), Industrial(17.17%) as on January 2025
The alpha ratio for the UTI Mid Cap Fund Direct Growth for various period is as follows:
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
UTI Mid Cap Fund Direct Growth | 0.08 | -3.37 | -0.33 |
As on January 2025
The alpha for UTI Mid Cap Fund Direct Growth is calculated against S&P BSE Midcap TR INR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the UTI Mid Cap Fund Direct Growth for various period is as follows:
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
UTI Mid Cap Fund Direct Growth | 1.09 | 0.9 | 0.88 |
As on January 2025
The Beta for UTI Mid Cap Fund Direct Growth is calculated with S&P BSE Midcap TR INR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the UTI Mid Cap Fund Direct Growth for various period is as follows:
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
UTI Mid Cap Fund Direct Growth | 0.35 | 0.63 | 0.87 |
As on January 2025
The sharpe ratio for UTI Mid Cap Fund Direct Growth is calculated with S&P BSE Midcap TR INR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the UTI Mid Cap Fund Direct Growth for various period is as follows:
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
UTI Mid Cap Fund Direct Growth | 16.7 | 15.11 | 19.99 |
As on January 2025
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.07 as on January 2025. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Ankit Agarwal is the fund manager of UTI Mid Cap Fund Direct Growth
The Exit load of UTI Mid Cap Fund Direct Growth is 1%